A systematic review and Bayesian meta-analysis of the antibiotic treatment courses in AECOPD
Background: No consensus exists on the antibiotic treatment course for patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Former studies indicate that shorter courses might have the same efficacy with fewer adverse events, which is inconsistent with guidelines and g...
Main Authors: | Haichuan Yu, Ting Lei, Xiaojie Su, Lu Zhang, Zhouzhou Feng, Xinlong Chen, Jian Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1024807/full |
Similar Items
-
Efficacy and safety of three species of Rhodiola L. in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
by: Haichuan Yu, et al.
Published: (2023-04-01) -
Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD
by: Haichuan Yu, et al.
Published: (2022-09-01) -
Real-world antibiotic use in treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in China: Evidence from the ACURE study
by: Yiming Ma, et al.
Published: (2021-05-01) -
The features of AECOPD with carbon dioxide retention
by: Xia Wei, et al.
Published: (2018-07-01) -
Prognostic value of lymphocyte count for in-hospital mortality in patients with severe AECOPD
by: Yanlu Hu, et al.
Published: (2022-10-01)